20th Jun 2023 16:41
FORM 8.3 Amendment to Purchase | |||||||
IRISH TAKEOVER PANEL | |||||||
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, | |||||||
TAKEOVER RULES, 2007 (AS AMENDED) | |||||||
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES | |||||||
REPRESENTING 1% OR MORE | |||||||
1. | KEY INFORMATION | ||||||
Name of person dealing (Note 1) | Barclays PLC. | ||||||
Company dealt in | HORIZON THERAPEUTICS PLC | ||||||
Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.001 ordinary shares | ||||||
Date of dealing | 14 Jun 2023 | ||||||
2. | INTERESTS AND SHORT POSITIONS | ||||||
(a) | Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) | ||||||
Class of relevant security: | $0.001 ordinary shares | ||||||
Long | Short | ||||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities | 1,156,262 | 0.51% | 698,966 | 0.31% | ||
(2) | Derivatives (other than options): | 140,756 | 0.06% | 98,064 | 0.04% | ||
(3) | Options and agreements to purchase/sell: | 1,404,500 | 0.61% | 961,400 | 0.42% | ||
TOTAL: | 2,701,518 | 1.18% | 1,758,430 | 0.77% | |||
(b) | Interests and short positions in relevant securities of the company, other than the class dealt in | ||||||
Class of relevant security: | Long | Short | |||||
Number | (%) | Number | (%) | ||||
(1) | Relevant securities |
|
|
|
| ||
(2) | Derivatives (other than options): |
|
|
|
| ||
(3) | Options and agreements to purchase/sell: |
|
|
|
| ||
TOTAL: |
|
|
|
| |||
3. | DEALINGS (Note 4) | ||||||
(a) | Purchase and sales |
| |||||
Class of relevant Security | Purchase/sale | Number of securities | Price per unit | ||||
$0.001 ordinary shares | Purchase | 12 | 100.0600 USD | ||||
$0.001 ordinary shares | Purchase | 79 | 100.1867 USD | ||||
$0.001 ordinary shares | Purchase | 93 | 100.0441 USD | ||||
$0.001 ordinary shares | Purchase | 100 | 100.2750 USD | ||||
$0.001 ordinary shares | Purchase | 100 | 100.2505 USD | ||||
$0.001 ordinary shares | Purchase | 124 | 99.9300 USD | ||||
$0.001 ordinary shares | Purchase | 200 | 100.2200 USD | ||||
$0.001 ordinary shares | Purchase | 250 | 100.0244 USD | ||||
$0.001 ordinary shares | Purchase | 313 | 100.1811 USD | ||||
$0.001 ordinary shares | Purchase | 314 | 100.1230 USD | ||||
$0.001 ordinary shares | Purchase | 333 | 100.1355 USD | ||||
$0.001 ordinary shares | Purchase | 367 | 100.1213 USD | ||||
$0.001 ordinary shares | Purchase | 507 | 100.2353 USD | ||||
$0.001 ordinary shares | Purchase | 1,123 | 100.1494 USD | ||||
$0.001 ordinary shares | Purchase | 2,645 | 100.2331 USD | ||||
$0.001 ordinary shares | Purchase | 3,040 | 100.2420 USD | ||||
$0.001 ordinary shares | Purchase | 4,698 | 100.6014 USD | ||||
$0.001 ordinary shares | Purchase | 7,625 | 100.2373 USD | ||||
$0.001 ordinary shares | Purchase | 7,982 | 100.4003 USD | ||||
$0.001 ordinary shares | Purchase | 8,828 | 100.2176 USD | ||||
$0.001 ordinary shares | Purchase | 9,865 | 100.0264 USD | ||||
$0.001 ordinary shares | Purchase | 11,739 | 100.6200 USD | ||||
$0.001 ordinary shares | Purchase | 21,159 | 100.5511 USD | ||||
$0.001 ordinary shares | Purchase | 33,347 | 100.4098 USD | ||||
$0.001 ordinary shares | Purchase | 143,900 | 105.0000 USD | ||||
$0.001 ordinary shares | Sale | 1 | 100.3200 USD | ||||
$0.001 ordinary shares | Sale | 1 | 100.1700 USD | ||||
$0.001 ordinary shares | Sale | 2 | 100.1150 USD | ||||
$0.001 ordinary shares | Sale | 12 | 100.1462 USD | ||||
$0.001 ordinary shares | Sale | 12 | 100.1891 USD | ||||
$0.001 ordinary shares | Sale | 12 | 100.2116 USD | ||||
$0.001 ordinary shares | Sale | 24 | 99.9300 USD | ||||
$0.001 ordinary shares | Sale | 60 | 100.2960 USD | ||||
$0.001 ordinary shares | Sale | 72 | 100.2745 USD | ||||
$0.001 ordinary shares | Sale | 76 | 100.4285 USD | ||||
$0.001 ordinary shares | Sale | 79 | 100.2235 USD | ||||
$0.001 ordinary shares | Sale | 79 | 100.1867 USD | ||||
$0.001 ordinary shares | Sale | 100 | 100.2000 USD | ||||
$0.001 ordinary shares | Sale | 100 | 100.3700 USD | ||||
$0.001 ordinary shares | Sale | 100 | 100.0200 USD | ||||
$0.001 ordinary shares | Sale | 100 | 99.9500 USD | ||||
$0.001 ordinary shares | Sale | 100 | 99.9100 USD | ||||
$0.001 ordinary shares | Sale | 115 | 100.2064 USD | ||||
$0.001 ordinary shares | Sale | 129 | 100.4900 USD | ||||
$0.001 ordinary shares | Sale | 150 | 100.1166 USD | ||||
$0.001 ordinary shares | Sale | 150 | 100.2466 USD | ||||
$0.001 ordinary shares | Sale | 183 | 100.0000 USD | ||||
$0.001 ordinary shares | Sale | 200 | 100.2400 USD | ||||
$0.001 ordinary shares | Sale | 200 | 100.0650 USD | ||||
$0.001 ordinary shares | Sale | 397 | 100.1010 USD | ||||
$0.001 ordinary shares | Sale | 517 | 100.0241 USD | ||||
$0.001 ordinary shares | Sale | 598 | 99.9858 USD | ||||
$0.001 ordinary shares | Sale | 900 | 99.9905 USD | ||||
$0.001 ordinary shares | Sale | 900 | 100.5244 USD | ||||
$0.001 ordinary shares | Sale | 997 | 100.3233 USD | ||||
$0.001 ordinary shares | Sale | 1,000 | 100.0135 USD | ||||
$0.001 ordinary shares | Sale | 1,226 | 100.4003 USD | ||||
$0.001 ordinary shares | Sale | 1,509 | 99.9944 USD | ||||
$0.001 ordinary shares | Sale | 1,525 | 100.1019 USD | ||||
$0.001 ordinary shares | Sale | 1,702 | 99.9527 USD | ||||
$0.001 ordinary shares | Sale | 2,000 | 99.9992 USD | ||||
$0.001 ordinary shares | Sale | 2,244 | 100.0771 USD | ||||
$0.001 ordinary shares | Sale | 3,245 | 100.2558 USD | ||||
$0.001 ordinary shares | Sale | 3,480 | 100.2838 USD | ||||
$0.001 ordinary shares | Sale | 4,557 | 100.2553 USD | ||||
$0.001 ordinary shares | Sale | 5,944 | 100.4256 USD | ||||
$0.001 ordinary shares | Sale | 6,175 | 100.6200 USD | ||||
$0.001 ordinary shares | Sale | 23,978 | 100.4961 USD | ||||
$0.001 ordinary shares | Sale | 39,893 | 100.3808 USD | ||||
| |||||||
(b) | Derivatives transactions (other than option transactions) | ||||||
Product Name | Nature of transaction | Number of relevant securities | Price per unit | ||||
|
|
|
| ||||
| |||||||
(c) | Options transactions in respect of existing securities | ||||||
(i) | Writing, selling, purchasing or varying | ||||||
Class of relevant security | Product description | Writing, purchasing, selling, varying etc | Number of securities to which option relates | Exercise price per unit | Type | Expiry date | Option money paid/ received per unit |
|
|
|
|
|
|
|
|
| |||||||
(ii) | Exercising |
| |||||
Product name | Number of securities | Exercise price per unit | |||||
|
|
| |||||
| |||||||
(d) | Other dealings (including transactions in respect of new securities) (Note 4) | ||||||
Nature of transaction | Details | Price per unit (if applicable) | |||||
|
|
| |||||
4. | OTHER INFORMATION | ||||||
Agreements, arrangements or understandings relating to options or derivatives | |||||||
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. | |||||||
NONE | |||||||
Is a Supplemental Form 8 (Open Positions) attached? | YES | ||||||
Date of disclosure: | 20 Jun 2023 | ||||||
Contact name: | Large Holdings Regulatory Operations | ||||||
Telephone number: | 020 3134 7213 | ||||||
If a connected EFM, name of offeree/offeror with which connected |
| ||||||
If a connected EFM, state nature of connection |
| ||||||
| |||||||
SUPPLEMENTAL FORM 8 | |||||||
| |||||||
IRISH TAKEOVER PANEL | |||||||
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL | |||||||
ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED) | |||||||
DETAILS OF OPEN POSITIONS | |||||||
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as | |||||||
appropriate) | |||||||
OPEN POSITIONS |
| ||||||
Class of relevant security | Product Description | Writing, purchasing, selling, varying etc | Number of securities to which option relates | Exercise price per unit | Type | Expiry date | |
$0.001 ordinary shares | Put Options | Written | 495,500 | 100 | American | 16 Jun 2023 | |
$0.001 ordinary shares | Call Options | Written | -25,000 | 115 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Put Options | Written | 28,800 | 095 | American | 21 Jul 2023 | |
$0.001 ordinary shares | Call Options | Written | -10,600 | 105 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Put Options | Written | 2,000 | 085 | American | 21 Jul 2023 | |
$0.001 ordinary shares | Put Options | Purchased | -250,000 | 080 | American | 16 Jun 2023 | |
$0.001 ordinary shares | Put Options | Written | 10,200 | 080 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Put Options | Written | 232,000 | 105 | American | 16 Jun 2023 | |
$0.001 ordinary shares | Call Options | Written | -2,600 | 100 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Call Options | Written | -2,000 | 100 | American | 21 Jul 2023 | |
$0.001 ordinary shares | Put Options | Written | 400,000 | 100 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Put Options | Written | 74,000 | 090 | American | 15 Sep 2023 | |
$0.001 ordinary shares | Put Options | Purchased | -544,200 | 080 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Put Options | Written | 162,000 | 105 | American | 21 Jul 2023 | |
$0.001 ordinary shares | Call Options | Written | -10,000 | 105 | American | 16 Jun 2023 | |
$0.001 ordinary shares | Put Options | Purchased | -10,200 | 100 | American | 18 Aug 2023 | |
$0.001 ordinary shares | Put Options | Purchased | -106,800 | 090 | American | 21 Jul 2023 | |
Related Shares:
Barclays